{"id":"W4283578471","doi":"10.1093/jncics/pkac047","title":"Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer","year":2022,"lang":"en","type":"article","venue":"JNCI Cancer Spectrum","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; Canadian Partnership Against Cancer; St. Michael's Hospital; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; University of Toronto; Queen's University; Women's College Hospital; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"FOLFIRINOX; Medicine; Gemcitabine; Cost effectiveness; Internal medicine; Propensity score matching; Oncology; Pancreatic cancer; Irinotecan; Folinic acid; Randomized controlled trial; Cancer; Fluorouracil; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003051128,0.0005039239,0.0007776413,0.0006218221,0.0003809658,0.001063427,0.0007916126,0.0004899584,0.002091576],"category_scores_gemma":[0.01221176,0.0002768161,0.002626403,0.001140547,0.000428613,0.0005164173,0.0005792624,0.0006672061,0.00007835147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02421262,"about_ca_system_score_gemma":0.00987702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4244023,"about_ca_topic_score_gemma":0.4013158,"domain_scores_codex":[0.9983292,0.0008322817,0.0001395542,0.0001854946,0.0002309616,0.0002823819],"domain_scores_gemma":[0.9964114,0.001372824,0.001426175,0.0001276755,0.0003174934,0.0003443733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07832422,0.002354018,0.5768543,0.003621893,0.01898609,0.0007326157,0.0004370784,0.2276673,0.00103636,0.002618332,0.004651851,0.08271601],"study_design_scores_gemma":[0.01279713,0.01057997,0.8313242,0.001121463,0.01196461,0.0005796074,0.000619018,0.1229251,0.0009216633,0.002414444,0.004608233,0.0001446329],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924181,0.00287319,0.0003754419,0.0005786233,0.00002330048,0.0002643491,0.002432366,0.00001080001,0.001023783],"genre_scores_gemma":[0.9981214,0.000432318,0.0002574718,0.00005723491,0.000007588727,0.00004853592,0.0009246986,0.000001587857,0.0001490965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4244023,"threshold_uncertainty_score":0.843864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0251690455597906,"score_gpt":0.34760438122919,"score_spread":0.3224353356693994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}